Northwest Biotherapeutics Inc (NASDAQ:NWBO)

8.18
Delayed Data
As of 4:00pm ET
 -0.06 / -0.73%
Today’s Change
3.79
Today|||52-Week Range
9.45
+52.90%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$506.7M

Company Description

Northwest Biotherapeutics, Inc. is a development stage company which is engaged in the development and discovery of innovative immunotherapy products to treat cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Contact Information

Northwest Biotherapeutics, Inc.
4800 Montgomery Lane
Bethesda Maryland 20814
P:(240) 497-9024
Investor Relations:
(202) 841-7909

Employees

Shareholders

Individual stakeholders7.49%
Other institutional3.55%
Mutual fund holders17.35%

Top Executives

Linda F. PowersChairman, President, CEO, CFO & CAO
Alton L. BoyntonChief Scientific Officer, Secretary & Director
Marnix L. BoschChief Technology Officer
Anthony E. MaidaSenior Vice President-Clinical Research
Leslie J. GoldmanSVP-Business Development & Head-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account